Saintlife Mediscience Profile
Key Indicators
- Authorised Capital ₹ 6.00 M
as on 24-10-2024
- Paid Up Capital ₹ 1.00 M
as on 24-10-2024
- Company Age 9 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.56 Cr
as on 24-10-2024
- Satisfied Charges ₹ 5.50 Cr
as on 24-10-2024
- Revenue %
(FY 2023)
- Profit 26.67%
(FY 2023)
- Ebitda 38.57%
(FY 2023)
- Net Worth -22.43%
(FY 2023)
- Total Assets -12.88%
(FY 2023)
About Saintlife Mediscience
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹6.56 Cr. The company has closed loans amounting to ₹5.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sanjay Nandwani and Sunil Nandwani serve as directors at the Company.
- CIN/LLPIN
U85100UR2015PTC001450
- Company No.
001450
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Mar 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Uttarakhand
Industry
Company Details
- Location
Dehradun, Uttarakhand, India
- Telephone
- Email Address
- Social Media-
Who are the key members and board of directors at Saintlife Mediscience?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Nandwani  | Director | 04-Oct-2019 | Current |
| Sunil Nandwani | Director | 04-Oct-2019 | Current |
Financial Performance of Saintlife Mediscience.
Saintlife Mediscience Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 26.67% increase in profit. The company's net worth observed a substantial decline by a decrease of 22.43%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Saintlife Mediscience?
In 2023, Saintlife Mediscience had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Himalaya Meditek Private LimitedActive 25 years 7 monthsSanjay Nandwani and Sunil Nandwani are mutual person
Saintlife Pharmaceuticals LimitedActive 8 years 4 monthsSanjay Nandwani and Sunil Nandwani are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 28 Dec 2018 | ₹6.56 Cr | Open |
Others Creation Date: 11 Nov 2016 | ₹2.00 Cr | Satisfied |
Others Creation Date: 02 Dec 2015 | ₹3.50 Cr | Satisfied |
How Many Employees Work at Saintlife Mediscience?
Saintlife Mediscience has a workforce of 1 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Saintlife Mediscience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Saintlife Mediscience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
